Income Statement Pharmaids Pharmaceuticals Limited

Stocks

PHARMAID

INE117D01018

Pharmaceuticals

Market Closed - Bombay S.E. 06:03:03 2026-09-11 EDT			5-day change	1st Jan Change
30.31 ^INR	+0.73%		-2.51%	-36.40%

08-12	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-29	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

2efe17c76949ebb8af368de2.V7gWRzVYnE40nCoUTjcRSgbb2QandEw9oKFrM3TFsEA.Be0mNWQI1gJn5md9PA91JTWvtHXSBzlV5sAsBkLygSQfySIFAQzbenyrGg

Published financial data: PHARMAIDS PHARMACEUTICALS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	39.39M	-	151M	194M	279M
Total Revenues	39.39M	-	151M	194M	279M
Cost of Goods Sold, Total	35.71M	9.04M	122M	132M	179M
Gross Profit	3.68M	-9.04M	28.66M	62.1M	99.64M
Selling General & Admin Expenses, Total	673K	13.12M	97.01M	144M	183M
Depreciation & Amortization - (IS)	92K	168K	17.25M	24.4M	20.27M
Other Operating Expenses	1.63M	73.05M	61.27M	45.2M	51.67M
Other Operating Expenses, Total	2.4M	86.33M	176M	214M	255M
Operating Income	1.28M	-95.37M	-147M	-152M	-156M
Interest Expense, Total	-	-13.08K	-15.42M	-20.07M	-32.78M
Interest And Investment Income	-	-	2.16M	935K	1.54M
Net Interest Expenses	-	-13.08K	-13.27M	-19.14M	-31.24M
Currency Exchange Gains (Loss)	-	-	-447K	-143K	1.04M
Other Non Operating Income (Expenses)	124K	-33.22K	6.2M	-783K	-835K
EBT, Excl. Unusual Items	1.4M	-95.42M	-154M	-172M	-187M
Gain (Loss) On Sale Of Investments	-	-	-320K	-	-
Gain (Loss) On Sale Of Assets	-	-	-202K	-	-
Asset Writedown	-	-3.66M	-1.31M	-	-
Other Unusual Items	-	-	-	-978K	23.61M
EBT, Incl. Unusual Items	1.4M	-99.08M	-156M	-173M	-163M
Income Tax Expense	-48.76K	-23.52M	-37.78M	-37.74M	-47.31M
Earnings From Continuing Operations	1.45M	-75.56M	-118M	-135M	-116M
Net Income to Company	1.45M	-75.56M	-118M	-135M	-116M
Minority Interest	-	-	38.75M	27.28M	-1.45M
Net Income - (IS)	1.45M	-75.56M	-79.68M	-108M	-117M
Net Income to Common Incl Extra Items	1.45M	-75.56M	-79.68M	-108M	-117M
Net Income to Common Excl. Extra Items	1.45M	-75.56M	-79.68M	-108M	-117M
Per Share Items
Net EPS - Basic	0.14	-5.86	-3.51	-3.06	-3.32
Basic EPS - Continuing Operations	0.14	-5.86	-3.51	-3.06	-3.32
Basic Weighted Average Shares Outstanding	10.31M	12.9M	22.72M	35.27M	35.27M
Net EPS - Diluted	0.14	-5.86	-3.51	-3.06	-3.32
Diluted EPS - Continuing Operations	0.14	-5.86	-3.51	-3.06	-3.32
Diluted Weighted Average Shares Outstanding	10.31M	12.9M	22.72M	35.27M	35.27M
Normalized Basic EPS	0.09	-4.62	-2.54	-2.27	-3.35
Normalized Diluted EPS	0.09	-4.62	-2.54	-2.27	-3.35
Supplemental Items
EBITDA	1.37M	-95.2M	-135M	-133M	-141M
EBITA	1.28M	-95.37M	-147M	-152M	-156M
EBIT	1.28M	-95.37M	-147M	-152M	-156M
EBITDAR	1.49M	-93.45M	-131M	-122M	-92.69M
Total Revenues (As Reported)	39.54M	-	160M	196M	282M
Effective Tax Rate - (Ratio)	-3.48	23.74	24.19	21.84	29.02
Total Deferred Taxes	-48.76K	-23.52M	-37.78M	-38.37M	-47.31M
Normalized Net Income	877K	-59.64M	-57.74M	-80.1M	-118M
Interest on Long-Term Debt	-	-	623K	3.84M	3.76M
Non-Cash Pension Expense	-	-	-	160K	420K
Supplemental Operating Expense Items
Advertising Expense	109K	58.72K	152K	1.34M	1.03M
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	109K	58.72K	152K	1.34M	1.03M
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	120K	1.75M	4.9M	11.29M	48.48M
Imputed Operating Lease Interest Expense	-	-	-	6.77M	37.09M
Imputed Operating Lease Depreciation	-	-	-	4.52M	11.39M
Maintenance & Repair Expenses, Total	-	162K	7.73M	8.34M	7.66M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	4.07M	128M	48.04M	21.44M	1.34M
Short Term Investments	-	33.05M	-	-	-
Total Cash And Short Term Investments	4.07M	161M	48.04M	21.44M	1.34M
Accounts Receivable, Total	13.39M	13.85M	26.79M	31.28M	44.91M
Other Receivables	-	-	-	-	26.3M
Notes Receivable	-	-	-	-	-
Total Receivables	13.39M	13.85M	26.79M	31.28M	71.2M
Inventory	8.88M	-	35.91M	124M	9.98M
Prepaid Expenses	-	-	1.57M	4.02M	2.25M
Other Current Assets, Total	339K	679K	23.01M	41.95M	25.14M
Total Current Assets	26.68M	175M	135M	223M	110M
Gross Property Plant And Equipment	9.59M	21.23M	412M	538M	336M
Accumulated Depreciation	-4.78M	-168K	-27.8M	-46.3M	-50.21M
Net Property Plant And Equipment	4.81M	21.06M	385M	492M	286M
Long-term Investments	-	-	-	-	17.26M
Goodwill	-	-	314M	314M	314M
Other Intangibles, Total	-	-	5.45M	5.45M	-
Accounts Receivable Long-Term	14.16M	6.69M	-	-	-
Deferred Tax Assets Long-Term	3.56M	27.08M	66.68M	105M	123M
Deferred Charges Long-Term	-	1.21M	-	-	-
Other Long-Term Assets, Total	61.92M	14.72M	7.2M	59M	22.32M
Total Assets	111M	246M	913M	1.2B	873M
Liabilities
Accounts Payable, Total	23.06M	18.83M	51.18M	163M	27.8M
Accrued Expenses, Total	-	-	4.62M	40.35M	75.87M
Short-term Borrowings	-	-	11.53M	40.57M	74.44M
Current Portion of Long-Term Debt	-	-	6.14M	18.58M	29.8M
Current Portion of Leases	-	-	7.13M	7.93M	6.42M
Current Income Taxes Payable	-	-	-	264K	-
Other Current Liabilities	1.35M	2.44M	35.16M	16.24M	25.75M
Total Current Liabilities	24.41M	21.27M	116M	287M	240M
Long-Term Debt	-	-	35.85M	324M	136M
Long-Term Leases	-	-	24.68M	29.35M	18.27M
Pension & Other Post Retirement Benefits	-	-	6.15M	7.78M	1.79M
Other Non Current Liabilities	-	-	26M	-1K	-
Total Liabilities	24.41M	21.27M	208M	648M	397M
Common Stock, Total	103M	214M	353M	353M	353M
Additional Paid In Capital	-	-	506M	506M	506M
Retained Earnings	-23.33M	-98.54M	-139M	-267M	-384M
Comprehensive Income and Other	7.36M	109M	1.34M	1.55M	2.05M
Total Common Equity	86.72M	225M	720M	593M	477M
Minority Interest	-	-	-15.5M	-42.79M	-510K
Total Equity	86.72M	225M	705M	550M	476M
Total Liabilities And Equity	111M	246M	913M	1.2B	873M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10.31M	21.49M	35.27M	35.27M	35.27M
ECS Total Common Shares Outstanding	10.31M	21.49M	35.27M	35.27M	35.27M
Book Value / Share	8.41	10.45	20.43	16.82	13.51
Tangible Book Value	86.72M	225M	401M	274M	162M
Tangible Book Value Per Share	8.41	10.45	11.37	7.76	4.6
Total Debt	0	0	85.33M	420M	265M
Net Debt	-4.07M	-161M	37.29M	399M	264M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	8.8M	2.88M
Debt Equivalent Oper. Leases	960K	14M	39.19M	90.31M	388M
Minority Interest, Total (Incl. Fin. Div)	-	-	-15.5M	-42.79M	-510K
Account Code - Inventory Valuation	6	6	6	5	5
Inventories - Raw Materials, Total	-	-	32.94M	9.8M	1.87M
Inventories - Work In Process, Total	-	-	-	1.16M	-
Inventories - Finished Goods, Total	8.88M	-	2.97M	111M	2.23M
Land - (BS)	-	-	178M	255M	76.16M
Buildings, Total	-	-	6.75M	27.87M	20.15M
Machinery, Total	5.09M	1.23M	120M	164M	141M
Full Time Employees	7	9	25	28	127
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	78.01M	78.01M	78.01M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	1.45M	-75.56M	-79.68M	-108M	-117M
Depreciation & Amortization - CF	92K	168K	17.25M	24.4M	20.27M
Depreciation & Amortization, Total	92K	168K	17.25M	24.4M	20.27M
(Gain) Loss From Sale Of Asset	-	306K	202K	960K	-24.84M
Asset Writedown & Restructuring Costs	-	-	6.23M	-	-
Provision and Write-off of Bad Debts	-	-	8.08M	-	-
Other Operating Activities, Total	-48.76K	-23.52M	-69.47M	-42.96M	-18.53M
Change In Accounts Receivable	-17.19M	7.01M	23.57M	-3.89M	-20.64M
Change In Inventories	-5.19M	8.88M	7.16M	-85.93M	96.17M
Change In Accounts Payable	18.04M	-4.23M	-12.4M	111M	-98.18M
Change in Other Net Operating Assets	248K	46.75M	-7.14M	-36.15M	122M
Cash from Operations	-2.59M	-40.19M	-106M	-140M	-40.57M
Capital Expenditure	-	-16.73M	-229M	-125M	-44.72M
Sale of Property, Plant, and Equipment	-	-	1.46M	2.18M	196M
Cash Acquisitions	-	-	-525M	-	-
Divestitures	-	-	-	-	76.42M
Investment in Marketable and Equity Securities, Total	-	-32.7M	-	-	-3.15M
Net (Increase) Decrease in Loans Originated / Sold - Investing	4.66M	-	-	-	-575K
Other Investing Activities, Total	-	-	2.08M	2.39M	9.58M
Cash from Investing	4.66M	-49.43M	-750M	-120M	233M
Long-Term Debt Issued, Total	-	-	15.3M	327M	70.57M
Total Debt Issued	-	-	15.3M	327M	70.57M
Long-Term Debt Repaid, Total	-	-	-24.56M	-56.67M	-256M
Total Debt Repaid	-	-	-24.56M	-56.67M	-256M
Issuance of Common Stock	-	213M	780M	-	-
Issuance of Preferred Stock	-	-	30M	-	-
Other Financing Activities, Total	-	-	-24.26M	-36.73M	-14.38M
Cash from Financing	-	213M	777M	234M	-200M
Miscellaneous Cash Flow Adjustments	-	-	-	-1K	-
Net Change in Cash	2.07M	123M	-79.5M	-26.6M	-6.89M
Supplemental Items
Cash Interest Paid	-	46K	12.37M	17.02M	14.38M
Cash Income Tax Paid (Refund)	-	-	-	629K	-
Levered Free Cash Flow	3.38M	-71.24M	-308M	-189M	-140M
Unlevered Free Cash Flow	3.38M	-71.23M	-298M	-176M	-119M
Change In Net Working Capital	-2.49M	-4.94M	-4.99M	-18.76M	-2.41M
Net Debt Issued / Repaid	-	-	-9.26M	270M	-185M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	0.79	-33.39	-15.84	-8.98	-9.39
Return on Total Capital	0.93	-38.29	-18.09	-10.59	-11.36
Return On Equity %	1.69	-48.54	-25.48	-21.52	-22.55
Return on Common Equity	1.69	-48.54	-16.86	-16.41	-21.91
Margin Analysis
Gross Profit Margin %	9.34	-	18.96	31.93	35.73
SG&A Margin	1.71	-	64.19	74.17	65.74
EBITDA Margin %	3.48	-	-89.66	-68.3	-50.63
EBITA Margin %	3.25	-	-97.19	-78.03	-55.8
EBIT Margin %	3.25	-	-97.19	-78.03	-55.8
Income From Continuing Operations Margin %	3.68	-	-78.37	-69.44	-41.5
Net Income Margin %	3.68	-	-52.73	-55.41	-42.02
Net Avail. For Common Margin %	3.68	-	-52.73	-55.41	-42.02
Normalized Net Income Margin	2.23	-	-38.21	-41.19	-42.36
Levered Free Cash Flow Margin	8.58	-	-203.69	-97.21	-50.13
Unlevered Free Cash Flow Margin	8.58	-	-197.31	-90.76	-42.78
Asset Turnover
Asset Turnover	0.39	-	0.26	0.18	0.27
Fixed Assets Turnover	8.12	-	0.75	0.44	0.72
Receivables Turnover (Average Receivables)	4.88	-	6.39	6.7	7.32
Inventory Turnover (Average Inventory)	5.68	-	-	1.65	2.67
Short Term Liquidity
Current Ratio	1.09	8.23	1.17	0.78	0.46
Quick Ratio	0.72	8.2	0.65	0.18	0.3
Operating Cash Flow to Current Liabilities	-0.11	-1.89	-0.92	-0.49	-0.17
Days Sales Outstanding (Average Receivables)	74.86	-	57.31	54.49	49.87
Days Outstanding Inventory (Average Inventory)	64.22	-	-	221.18	136.83
Average Days Payable Outstanding	125.27	-	-	177.29	538.02
Cash Conversion Cycle (Average Days)	13.81	-	-	98.38	-351.32
Long Term Solvency
Total Debt/Equity	-	-	12.1	76.35	55.75
Total Debt / Total Capital	-	-	10.8	43.3	35.79
LT Debt/Equity	-	-	8.59	64.17	32.5
Long-Term Debt / Total Capital	-	-	7.66	36.39	20.87
Total Liabilities / Total Assets	21.96	8.65	22.82	54.08	45.45
EBIT / Interest Expense	-	-7.29K	-9.52	-7.56	-4.75
EBITDA / Interest Expense	-	-7.28K	-8.4	-6.35	-4.13
(EBITDA - Capex) / Interest Expense	-	-8.56K	-23.23	-12.56	-5.49
Total Debt / EBITDA	-	-	-0.66	-3.3	-1.96
Net Debt / EBITDA	-2.97	1.69	-0.29	-3.13	-1.95
Total Debt / (EBITDA - Capex)	-	-	-0.24	-1.67	-1.47
Net Debt / (EBITDA - Capex)	-2.97	1.43	-0.1	-1.58	-1.47
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-53.93	-	-	28.69	43.37
Gross Profit, 1 Yr. Growth %	-6.17	-345.75	-417.09	138.71	72.24
EBITDA, 1 Yr. Growth %	28.22	-7.08K	36.99	3.1	6.29
EBITA, 1 Yr. Growth %	105.96	-7.56K	48.24	8.24	2.53
EBIT, 1 Yr. Growth %	105.96	-7.56K	48.24	8.24	2.53
Earnings From Cont. Operations, 1 Yr. Growth %	55.55	-5.31K	56.74	14.03	-14.32
Net Income, 1 Yr. Growth %	55.55	-5.31K	5.46	35.25	8.73
Normalized Net Income, 1 Yr. Growth %	58.61	-6.9K	-6.76	49.52	48.04
Diluted EPS Before Extra, 1 Yr. Growth %	55.56	-4.29K	-40.15	-12.88	8.73
Accounts Receivable, 1 Yr. Growth %	382.85	3.49	30.4	16.78	43.55
Inventory, 1 Yr. Growth %	140.48	-	-	244.91	-91.98
Net Property, Plant and Equip., 1 Yr. Growth %	-1.88	338.23	1.73K	27.88	-41.81
Total Assets, 1 Yr. Growth %	21.91	121.26	271.53	31.21	-27.19
Tangible Book Value, 1 Yr. Growth %	1.7	159.01	78.47	-31.75	-40.65
Common Equity, 1 Yr. Growth %	1.7	159.01	220.78	-17.66	-19.67
Cash From Operations, 1 Yr. Growth %	-163.99	1.45K	164.22	31.75	-73.15
Capital Expenditures, 1 Yr. Growth %	-	-	1.27K	-45.41	-64.17
Levered Free Cash Flow, 1 Yr. Growth %	-4.55	-2.21K	277.21	-38.55	-26.06
Unlevered Free Cash Flow, 1 Yr. Growth %	-4.55	-2.21K	265.4	-40.77	-32.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	95.86	-	35.83
Gross Profit, 2 Yr. CAGR %	499.02	51.85	179.14	162.13	95.7
EBITDA, 2 Yr. CAGR %	-36.08	843.62	897.01	15.88	4.68
EBITA, 2 Yr. CAGR %	-41.55	1.14K	971.62	23.76	5.35
EBIT, 2 Yr. CAGR %	-41.55	1.14K	971.62	23.76	5.35
Earnings From Cont. Operations, 2 Yr. CAGR %	108.05	799.85	803.31	33.69	-1.15
Net Income, 2 Yr. CAGR %	108.05	799.85	640.93	19.43	21.26
Normalized Net Income, 2 Yr. CAGR %	-38.86	938.73	711.54	13.73	48.48
Diluted EPS Before Extra, 2 Yr. CAGR %	116.03	706.92	400.52	-27.79	-2.67
Accounts Receivable, 2 Yr. CAGR %	-	123.54	41.46	23.4	29.48
Inventory, 2 Yr. CAGR %	-	-	101.15	-	-47.4
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.05	107.36	794.56	383.23	-13.74
Total Assets, 2 Yr. CAGR %	14.62	64.24	186.7	120.8	-2.26
Tangible Book Value, 2 Yr. CAGR %	1.4	62.3	115	10.37	-36.36
Common Equity, 2 Yr. CAGR %	1.4	62.3	188.24	62.52	-18.67
Cash From Operations, 2 Yr. CAGR %	-41.1	214.91	539.92	86.57	-38.19
Capital Expenditures, 2 Yr. CAGR %	-	3.24K	-	173.14	-55.77
Levered Free Cash Flow, 2 Yr. CAGR %	-68.86	348.49	855.34	52.2	-32.6
Unlevered Free Cash Flow, 2 Yr. CAGR %	-68.86	348.47	840.26	47.07	-36.73
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	91.48	-	20.9	70.27	-
Gross Profit, 3 Yr. CAGR %	21.53	345.1	94.09	156.54	122.56
EBITDA, 3 Yr. CAGR %	10.45	205	402.29	360.17	12.59
EBITA, 3 Yr. CAGR %	-4.66	194.25	518.43	391.39	16.24
EBIT, 3 Yr. CAGR %	-4.66	194.25	518.43	391.39	16.24
Earnings From Cont. Operations, 3 Yr. CAGR %	-6.46	508.5	402.55	353.14	15.27
Net Income, 3 Yr. CAGR %	-6.46	508.5	340.36	320.3	15.75
Normalized Net Income, 3 Yr. CAGR %	-0.64	194.08	370.96	350.4	24.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.63	480.23	239.03	179.46	-17.24
Accounts Receivable, 3 Yr. CAGR %	35.66	-	112.99	32.7	29.78
Inventory, 3 Yr. CAGR %	-	-	113.48	141.08	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-3.18	58.08	328.21	367.74	138.63
Total Assets, 3 Yr. CAGR %	8.64	42.72	115.59	120.94	52.54
Tangible Book Value, 3 Yr. CAGR %	1.07	38.61	67.52	46.67	-10.25
Common Equity, 3 Yr. CAGR %	1.07	38.61	103.68	89.83	28.5
Cash From Operations, 3 Yr. CAGR %	37.16	75.19	197.01	277.86	0.31
Capital Expenditures, 3 Yr. CAGR %	-	240.54	2.38K	-	38.78
Levered Free Cash Flow, 3 Yr. CAGR %	-55.4	26.91	342.95	282.7	19.65
Unlevered Free Cash Flow, 3 Yr. CAGR %	-55.4	26.91	338.28	274.04	13.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	26.78	-	93.22	-	26.67
Gross Profit, 5 Yr. CAGR %	-6.98	81.99	69.49	260.14	91
EBITDA, 5 Yr. CAGR %	-16.78	89.84	166	108.69	165.54
EBITA, 5 Yr. CAGR %	-20.67	89.8	150.94	109.69	201.85
EBIT, 5 Yr. CAGR %	-20.67	89.8	150.94	109.69	201.85
Earnings From Cont. Operations, 5 Yr. CAGR %	5.76	81.3	131.71	231.9	162.24
Net Income, 5 Yr. CAGR %	5.76	81.3	114.05	217.25	162.89
Normalized Net Income, 5 Yr. CAGR %	-20.34	91.7	130.17	102.63	192.38
Diluted EPS Before Extra, 5 Yr. CAGR %	-15.24	38.92	82.77	152.12	105.8
Accounts Receivable, 5 Yr. CAGR %	11.19	21.86	37.95	-	74.54
Inventory, 5 Yr. CAGR %	29.41	-	-	-	22
Net Property, Plant and Equip., 5 Yr. CAGR %	-	292.84	135.62	147.17	125.59
Total Assets, 5 Yr. CAGR %	40.63	80.16	60.16	69.93	57.11
Tangible Book Value, 5 Yr. CAGR %	43.45	84.8	36.69	26.54	13.75
Common Equity, 5 Yr. CAGR %	43.45	84.8	53.7	47.72	41.08
Cash From Operations, 5 Yr. CAGR %	-4.46	79.92	153.98	79.66	58.52
Capital Expenditures, 5 Yr. CAGR %	-	246.69	329.1	211.78	395.31
Levered Free Cash Flow, 5 Yr. CAGR %	24.05	506.68	51.87	40.24	108.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.42	506.67	50.91	38.33	102.06